Combining octreotide with lipophilic counter-ions and lipid-based formulations improved oral peptide stability against gut enzymes and enhanced intestinal membrane permeability — advancing oral delivery of this important peptide drug.
Dual barrier solvedLipophilic salt form protects against gut enzymes while lipid carrier enhances membrane crossing — addressing both major oral peptide delivery barriers simultaneously
What the researchers found
Lipophilic salt forms of octreotide in lipid-based formulations improved enzymatic stability in GI lumen and intestinal membrane permeability, addressing both major barriers to oral peptide delivery.
Why it matters
Octreotide injections are burdensome for patients with chronic conditions. An oral formulation would dramatically improve quality of life and treatment adherence for patients needing long-term octreotide therapy.
The numbers in context
OCT.DoS2 + SEDDS higher absorption; no permeability increase in Caco-2/in situ; reduced enzymatic degradation; prolonged lipid retention
How the study worked
Pharmaceutical formulation study. Lipophilic counter-ion pairing with octreotide. Lipid-based formulation optimization. Enzymatic stability testing. Intestinal permeability assessment.
Who was studied
Male Sprague-Dawley rats
What this study cannot tell us
In vitro formulation study. In vivo oral bioavailability not tested. Lipid-based formulations face stability and manufacturing challenges. Food effects on absorption unknown.
How to read the evidence
Low evidence grade: in vitro formulation study. Oral bioavailability confirmation needed.
When this study was published
Published 2021. Oral octreotide (Mycapssa) was actually approved — validating the oral delivery concept for this peptide.
The bigger picture
The lipophilic salt + lipid formulation strategy is applicable to many peptide drugs beyond octreotide. If proven clinically, this approach could transform oral delivery for the entire peptide drug class.
Questions still open
- Would oral lipophilic octreotide achieve therapeutic plasma levels?
- Can this formulation approach be applied to other peptide drugs?
- How does food intake affect oral octreotide absorption from lipid formulations?
Common questions
Can octreotide be taken as a pill?
Why is oral peptide delivery so difficult?
Read the original research
Lipophilic Salts and Lipid-Based Formulations: Enhancing the Oral Delivery of Octreotide.
Pharmaceutical research, 38(6), 1125-1137
Citation
Li, Peng; Ford, Leigh; Haque, Shadabul; McInerney, Mitchell P; Williams, Hywel D; Scammells, Peter J; Thompson, Philip E; Jannin, Vincent; Porter, Christopher J H; Benameur, Hassan; Pouton, Colin W. (2021). Lipophilic Salts and Lipid-Based Formulations: Enhancing the Oral Delivery of Octreotide.. Pharmaceutical research, 38(6), 1125-1137. https://doi.org/10.1007/s11095-021-03063-3